Binding and transport of melanoma-specific antigenic peptides by the transporter associated with antigen processing

Molecular Immunology

Volumn 33, Issue 15, 1996, Pages 1165-1169

  Chang, Spencer A ^a   Lacaille, Vashti G ^a   Guttoh, David S ^a   Androlewicz, Matthew J ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

antigen processing; melanoma; peptide transport

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MELANOMA ANTIGEN; SYNTHETIC PEPTIDE;

ANTIGEN PRESENTATION; ARTICLE; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; ATP-BINDING CASSETTE TRANSPORTERS; EPITOPES; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; PEPTIDES; PROTEIN BINDING;

EID: 0030268198     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(96)00082-X     Document Type: Article

References (22)

1. Androlewicz M. J. and Cresswell P. (1994) Human transporters associated with antigen processing possess a promiscuous peptide-binding site. Immunity 1, 7-14.
2. Androlewicz M. J., Ortmann B., Endert P. M. van, Spies T. and Cresswell P. (1994) Characteristics of peptide and major histocompatibility complex class I/b2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2). Proc. natn. Acad. Sci. U.S.A. 91, 12716-12720.
3. Boel P., Wildmann C., Sensi M. L., Brasseur R., Renauld J.-C., Coulie P., Boon T., Bruggen P. van der (1995) BAGE: a new gene encoding an antigen recognized on human melamomas by cytolytic T lymphocytes. Immunity 2, 167-175.
4. Bruggen P. van der, Szikora J. P., Boel P., Wildmann C., Somville M. and Sensi M., Boon T. (1994) Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw1601. Eur. J. Immun. 24, 2134-2140.
5. Castelli C., Storkus W. J., Maeurer M. J., Martin D. M., Huang E. C., Pramanik B. N., Nagabhushan T. L., Parmiani G. and Lotze M. T. (1995) Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8 + cytotoxic T lymphocytes. J. Exp. Med. 181, 363-368.
6. Cox A. L., Skipper J., Chen Y., Henderson R. A., Darrow T. L., Shabanowitz J., Engelhard V. H., Hunt D. F. and Slingluff C. L. Jr (1994) Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell tines. Science 264, 716-719.
7. Endert P. M. van, Riganelli D., Greco G., Fleischhauer K., Sidney J., Sette A. and Bach J.-F. (1995) The peptide-binding motif for the human transporter associated with antigen processing. J. Exp. Med. 182, 1883-1895.
8. Gaugler B., Van den Eynde B.. Bruggen P. van der, Romero P., Gaforio J. J., De Plaen E., Lethe B., Brasseur F. and Boon T. (1994) Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179, 921-930.
9. Lehner P. J. and Cresswell P. (1996) Processing and delivery of peptides presented by MHC class I molecules. Curr. Opin. Immun. 8, 59-67.
10. Herlyn M., Clark W. H. Jr, Mastrangelo M. J., Guerry D. Jr IV, Elder D. E., LaRossa D., Hamilton R., Bondi E., Tuthill R., Steplewski Z. and Koprowski H. (1980) Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells. Cancer Res. 40, 3602-3609.
11. Jardetzky T. S., Lane W. S., Robinson R. A., Madden D. R. and Wiley D. C. (1991) Identification of self peptides bound to purified HLA-B27. Nature 353, 326-329.
12. Kawakami Y., Eliyahu S., Delgado C. H., Robbins P. F., Rivoltini L., Topalian S. L., Miki T. and Rosenberg S. A. (1994) Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. natn. Acad. Sci. U.S.A. 91, 3515-3519.
13. Koenig S., Fuerst T. R., Wood L. V., Woods R. M., Suzich J, A.. Jones G. M., De La Cruz V. F., Davey R. T. Jr, Venkatesan S., Moss B., Biddison W. E. and Fauci A. S. (1990) Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein. J. Immun. 145, 127-135.
14. Pulvertaft R. J. V. (1964) Cytology of Burkitt's tumour. Lancet 1, 238-240.
15. Robbins P. F., El-Gamil M., Li Y. F., Topalian S. L., Rivoltini L., Sakaguchi K., Apella E., Kawakami Y. and Rosenberg S. A. (1995) Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-24-restricted tumor-infiltrating lymphocytes. J. Immun. 154, 5944-5950.
16. Skipper J. C. A., Hendrickson R. C., Gulden P. H.; Brichard V., Van Pel A., Chen Y., Shabanowitz J., Wolfel T., Slingluff C. L. Jr. Boon T., Hunt D. F. and Engelhard V. H. (1996) An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J. Exp. Med. 183, 527-534.
17. Traversari C., Bruggen P. van der, Luescher I. F., Lurquin C., Chomez P., Van Pel A., De Plaen E., Amar-Costesec A. and Boon T. (1992) A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med. 176, 1453-1457.
18. Van den Eynde B. and Britchard V. G. (1995) New tumor antigens recognized by T cells. Curr. Opin. Immuno. 7, 674-681.
19. Van den Eynde B., Peeters O., De Backer O., Gaugler B. and Lucas S., Boon T. (1995) A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182, 689-698.
20. Wang R.-F., Robbins P. F., Kawakami Y., Kang X.-Q. and Rosenberg S. A. (1995) Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J. Exp. Med. 181, 799-804.
21. WHO Nomenclature Committee (1990) Nomenclature for factors of the HLA system, 1989. Immunogenetics. 31, 131 140.
22. Wolfel T., Van Pel A., Brichard V., Schneider J., Seliger B., Meyer zum Buschenfelde K.-H. and Boon T. (1994) Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immun. 24, 759-774.